Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants. In addition, it sells medical devices; provides technology services; and engages in research and development. Osteopore Limited was incorporated in 2018 and is headquartered in Perth, Australia.